Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 2 1

Status

Recruiting 2Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 6OTHER 5NIH 2NETWORK 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Head & Neck 4Endocrine 2

Conditions

Thyroid Neoplasms 3Thyroid Diseases 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Carcinoma, Medullary 1Cachexia-Anorexia Syndrome 1Advanced Thyroid Cancer Patients Who Received Target Therapy 1

Interventions

pembrolizumab 593Cyclophosphamide 539Magnetic Resonance Spectroscopy 527Radiotherapy 506Specimen Handling 504Nivolumab 406Cisplatin 370Carboplatin 360Biopsy 306Blood Specimen Collection 296Radiosurgery 284Paclitaxel 276Surveys and Questionnaires 269Standard of Care 267Gemcitabine 266fludarabine 261Dexamethasone 258Drug Therapy 256Bevacizumab 248venetoclax 247Oxaliplatin 206Rituximab 197Capecitabine 194Radiation 190Fluorouracil 186Ipilimumab 183durvalumab 181Doxorubicin 174atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × selpercatinib × 1 year × Clear all
NCT04759911 2026-05-20

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
30 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT07543887 2026-04-22

EECRTKI

University of Pisa

Completed
15 enrolled
Head & Neck

Thyroid Diseases, Thyroid Neoplasms

NCT07419932 2026-02-19

NeoLATC

Fujian Medical University

Recruiting
120 enrolled
Head & Neck

Thyroid Neoplasms

NCT07146893 2026-01-15

FEATHER

University of Oklahoma

Phase EARLY_PHASE1 Not yet recruiting
7 enrolled

Cachexia-Anorexia Syndrome

NCT06195228 2025-08-14

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Fudan University

Phase 4 Recruiting
800 enrolled
EndocrineHead & Neck

Advanced Thyroid Cancer Patients Who Received Target Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡